Join us for keynotes on Good Clinical Practice and the hidden costs of clinical trials (from the study site and sponsor perspectives).
The 3 C’s - Compliance, Costs and Collaboration
ICH - E6 (R2) GCP Revision Update
Jean Smart, Regulatory Consultant, BC Clinical Research Infrastructure Network
Trading Places: How Emerging Markets Are Winning the Investigator Site War, and How Canadian Sites can Battle Back
Robert Huizinga, Vice President Clinical Affairs, Aurinia Pharma
Negotiating Clinical Trials Budgets: Remaining Compliant & Competitive
Laura Harvey, Finance and Regulatory Manager, MS & NMO Clinical Trials Group